Sunday 18 October 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGM Healthcare Medical Devices
Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023. In the quarter to June 2026, revenue fell 33.5%, EPS fell 15.4%, free cash flow fell 12.9% and total debt rose 46.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.10
0.00
0.00%
Follow ADGM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
— | 27.19 | 0.00 | — | — | — | — | — |
Altman Z-Score |
— | (6.98) | (48.16) | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | (13.31) | (132.61) | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
— | (2.30) | (1.17) | — | — | — | — | — |
P/B ratio |
— | 0.82 | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/Sales |
— | 19.70 | 0.00 | — | — | — | — | — |
EV/EBITDA |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | (0.40) | (0.28) | — | — | — | — | — |
EV/FCF |
— | (0.38) | (0.27) | — | — | — | — | — |
Quick Ratio |
2.08 | 2.66 | 0.03 | 0.01 | 0.08 | 0.00 | 0.00 | — |
Current Ratio |
2.44 | 3.27 | 0.11 | 0.02 | 0.15 | 0.03 | 0.03 | — |
Net Debt/EBITDA |
(0.19) | 0.09 | 0.05 | 0.09 | 0.08 | 0.00 | 0.00 | — |
Debt/Assets |
48.64% | 33.18% | 2.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.70 | 0.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.76 | 0.39 | 0.70 | (0.45) | 0.16 | 0.00 | 0.00 | — |
Capex/Depreciation |
(0.39) | (0.05) | (0.62) | — | — | — | — | — |
Interest Coverage |
(7.53) | (28.79) | (16.84) | — | — | — | — | — |
| (155.25%) | 133.87% | 52.02% | (11.27%) | 127.31% | 100.00% | 100.00% | — | |
| (54.71%) | (271.53%) | (46.14%) | 0.71% | (8.72%) | (31.76%) | (63.53%) | — | |
ROIC |
(83.74%) | (341.51%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(187.42%) | (383.90%) | 90.34% | (17.43%) | 128.28% | 24.91% | 24.91% | — |
Average Days of Receivables |
— | 21.22 | 86.38 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 2,029.73% | 5,133.00% | — | — | — | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 3,326.08% | 3,845.67% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.48 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 106.64% | 147.33% | — | — | — | — | — |
Graham Net Nets |
— | (0.19) | (5.08) | — | — | — | — | — |
Graham Number |
— | 0.00 | 433.79 | — | — | — | — | — |
Earnings Yield |
— | (458.46%) | (440.48%) | — | — | — | — | — |
Free Cash Flow Yield |
— | (190.04%) | (312.90%) | — | — | — | — | — |
Revenue per Share |
0.00 | 0.04 | 0.39 | 0.00 | 0.00 | 0.00 | — | — |
Operating CF per Share |
(1.15) | (1.89) | (33.75) | (0.13) | (0.29) | 0.00 | 0.00 | — |
Capex per Share |
(0.02) | (0.11) | (0.45) | 0.00 | 0.00 | 0.00 | — | — |
Free Cash Flow per Share |
(1.17) | (2.00) | (34.20) | (0.13) | (0.29) | 0.00 | 0.00 | — |
Cash per Share |
1.03 | 1.32 | 1.82 | 0.02 | 0.14 | 0.00 | — | — |
Shareholders Equity per Share |
0.75 | 1.28 | (53.36) | (2.31) | (2.84) | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Book value per Share |
0.75 | 1.28 | (53.36) | (2.31) | (2.84) | 0.00 | 0.00 | — |
Free Cash Flow |
(19.39) | (31.11) | (25.99) | (0.49) | (1.07) | 0.00 | 0.00 | — |
Working Capital |
11.85 | 17.59 | (41.99) | (6.12) | (5.12) | (0.05) | (0.05) | — |
Capital Expenditures |
(0.37) | (1.65) | (0.34) | — | — | — | — | — |
Net Current Asset Value |
(10.77) | (3.19) | (42.19) | (160.27) | (159.85) | (0.05) | (0.05) | — |
EV/EBIT |
— | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.00 | 2.74 | 1.13 | — | — | — | — | — |
Price to Operating Income |
— | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.63 | 16.18 | 0.37 | — | — | — | — | — |
Cash ROIC |
(38.36%) | (54.98%) | 66.60% | 5.68% | 10.93% | 0.00% | 0.00% | — |
Accounts Receivable Turnover |
— | 11.36 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.35 | 0.99 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
0.32 | 1.13 | 0.00 | — | — | — | — | — |
Average Days of Payables |
577.38 | 312.42 | 1,070.41 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
892.22 | 282.28 | 928.43 | — | — | — | — | — |
Average Receivables |
— | 0.05 | — | — | — | — | — | — |
Average Payables |
1.96 | 3.34 | 1.95 | 0.12 | 0.10 | 0.03 | 0.03 | — |
Average Inventory |
2.12 | 2.94 | — | — | — | — | — | — |
Average Assets |
45.85 | 27.64 | 79.30 | 151.10 | 75.23 | 0.04 | 0.02 | — |
Average Common Equity |
16.16 | (56.06) | (70.33) | (9.47) | (5.15) | (0.01) | (0.01) | — |
Columns are period end dates